Sheryl Simms
Optometrist · Chandler, AZNPI 1710926704
Payments from drug & device makers
Across 51 payments — averaging $88.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$3K
- Glaukos Corporation$263
- Johnson & Johnson Vision Care, Inc.$220
- Bausch & Lomb Americas Inc.$198
- Synergeyes, Inc.$147
- Bausch & Lomb, A Division Of Bausch Health US, LLC$143
- plus $438 from 7 others
What the payments were for
- Speaking & faculty fees$2,67059%
- Food & beverage$1,82341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 17 | $3,086 |
| Glaukos Corporation | 2 | $263 |
| Johnson & Johnson Vision Care, Inc. | 8 | $220 |
| Bausch & Lomb Americas Inc. | 3 | $198 |
| Synergeyes, Inc. | 4 | $147 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $143 |
| AbbVie | 1 | $116 |
| Tarsus Pharmaceuticals, Inc. | 1 | $91 |
| Visioneering Technologies, Inc. | 4 | $73 |
| Alcon | 4 | $69 |
| Topcon Healthcare Solutions, Inc. | 1 | $57 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| ABB Con-cise Optical Group LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MiSight Contact Lens$2,670
- CE-marked KXLA system$148
- RESTASIS$116
- iStent inject W$115
- Acuvue$101
How this compares
$4,493 in reported general payments places this provider in the 90th percentile of 1,134 optometrist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 12 | $486 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Chandler
- Catherine HollenbachChandler$10K
- Paul WagnerChandler$6K
- Marc BloomensteinScottsdale$2.3M
- Stephanie WooLake Havasu City$540K
- Kevin HelmuthSacaton$281K
- Christina SorensonGlendale$181K
- Jashpal RajasansiGilbert$120K
- Michelle Marie MijaresFort Defiance$38K
- Jamie KuhnGlendale$37K
- Tania SobchukLake Havasu City$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.